Dipartimento di Scienze di Laboratorio e Infettivologiche, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Rome, Italy; Dipartimento di Scienze Biotecnologiche di Base, Cliniche Intensivologiche e Perioperatorie, Università Cattolica del Sacro Cuore, Rome, Italy.
IRCCS Humanitas Research Hospital, Rozzano (MI), Italy and Institute of Genetic and Biomedical Research (IRGB) - UoS Milan, National Research Council (CNR), Milan, Italy.
Microbiol Res. 2022 Oct;263:127152. doi: 10.1016/j.micres.2022.127152. Epub 2022 Jul 30.
Antibiotic resistance is a serious health and social problem that will have a substantial impact in the coming years on the world health and economy. Thus, the increasing demand for innovative antibiotics, has prompted many researchers in the medical, microbiological, and biochemical fields to exploit the properties of antimicrobial peptides (AMPs). When properly used, designed, and conveyed, AMPs can really represent a valid alternative to conventional drugs especially in situations that are particularly difficult to treat such as chronic infections found in Cystic Fibrosis (CF) patients. In this review we focused on the applications of AMPs in the specific field of CF, illustrating different types of peptides from natural, naturally modified, synthetic as well as the different strategies used to overcome the barriers, and the physiological conditions in which AMPs must operate.
抗生素耐药性是一个严重的健康和社会问题,在未来几年将对世界健康和经济产生重大影响。因此,对抗生素的需求不断增加,促使许多医学、微生物学和生物化学领域的研究人员利用抗菌肽(AMPs)的特性。当 AMPs 被正确地使用、设计和传达时,它们确实可以成为传统药物的有效替代品,特别是在一些特别难以治疗的情况下,例如囊性纤维化(CF)患者中发现的慢性感染。在这篇综述中,我们重点介绍了 AMPs 在 CF 这一特定领域的应用,展示了不同类型的肽,包括天然、天然修饰、合成以及用于克服障碍和 AMPs 必须运作的生理条件的不同策略。